tiprankstipranks
Advertisement
Advertisement

DXCM Stock Latest News

DexCom price target raised to $84 from $77 at Citi
The FlyDexCom price target raised to $84 from $77 at Citi
1M ago
DXCM
Dexcom Executive Chairman Kevin Sayer Returns From Leave
PremiumCompany Announcements
Dexcom Executive Chairman Kevin Sayer Returns From Leave
1M ago
8K
DXCM
Dexcom Adds Google Executive Rick Osterloh to Board
PremiumCompany Announcements
Dexcom Adds Google Executive Rick Osterloh to Board
1M ago
8K
DXCM
DexCom management to meet virtually with BTIG
PremiumThe Fly
DexCom management to meet virtually with BTIG
1M ago
DXCM
Dexcom’s $750 Million 2025 Buyback Plan Faces Uncertain Execution and Limited Assurance of Shareholder Value
PremiumCompany Announcements
Dexcom’s $750 Million 2025 Buyback Plan Faces Uncertain Execution and Limited Assurance of Shareholder Value
2M ago
DXCM
DexCom Earnings Call Highlights Margin Rebound, Growth
PremiumCompany AnnouncementsDexCom Earnings Call Highlights Margin Rebound, Growth
2M ago
DXCM
Early notable gainers among liquid option names on February 13th
Premium
The Fly
Early notable gainers among liquid option names on February 13th
2M ago
ABNB
AMAT
DexCom price target raised to $87 from $82 at Baird
Premium
The Fly
DexCom price target raised to $87 from $82 at Baird
2M ago
DXCM
DexCom price target raised to $90 from $78 at Mizuho
PremiumThe Fly
DexCom price target raised to $90 from $78 at Mizuho
2M ago
DXCM
Dexcom: Solid Q4 Execution, Durable Growth Drivers, and Innovation Pipeline Underpin Buy Rating and $85 Target
PremiumRatings
Dexcom: Solid Q4 Execution, Durable Growth Drivers, and Innovation Pipeline Underpin Buy Rating and $85 Target
2M ago
DXCM
DexCom price target lowered to $95 from $99 at Canaccord
PremiumThe Fly
DexCom price target lowered to $95 from $99 at Canaccord
2M ago
DXCM
DexCom price target raised to $72 from $71 at Barclays
PremiumThe Fly
DexCom price target raised to $72 from $71 at Barclays
2M ago
DXCM
Dexcom: Sustained Revenue Outperformance and Margin Expansion Underpin Buy Rating
PremiumRatingsDexcom: Sustained Revenue Outperformance and Margin Expansion Underpin Buy Rating
2M ago
DXCM
DexCom reports Q4 adjusted EPS 68c, consensus 65c
Premium
The Fly
DexCom reports Q4 adjusted EPS 68c, consensus 65c
2M ago
DXCM
DexCom sees FY26 revenue $5.16B-$5.25B, consensus $5.23B
Premium
The Fly
DexCom sees FY26 revenue $5.16B-$5.25B, consensus $5.23B
2M ago
DXCM
Notable companies reporting after market close
PremiumThe Fly
Notable companies reporting after market close
2M ago
ABNB
AMAT
DXCM Earnings this Week: How Will it Perform?
PremiumPre-Earnings
DXCM Earnings this Week: How Will it Perform?
2M ago
DXCM
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
LVS
TZA
Dexcom: Strong 2025 Outperformance, Durable CGM Growth Runway, and Upcoming Product Catalysts Support Buy Rating
PremiumRatings
Dexcom: Strong 2025 Outperformance, Durable CGM Growth Runway, and Upcoming Product Catalysts Support Buy Rating
3M ago
DXCM
Dexcom: 2026 Reset Year Sets Stage for Renewed Growth and Upside Potential
PremiumRatingsDexcom: 2026 Reset Year Sets Stage for Renewed Growth and Upside Potential
3M ago
DXCM
Midday Fly By: Alphabet hits $4T market cap, Walmart to join Nasdaq-100
Premium
The Fly
Midday Fly By: Alphabet hits $4T market cap, Walmart to join Nasdaq-100
3M ago
BA
ALB
Early notable gainers among liquid option names on January 12th
Premium
The Fly
Early notable gainers among liquid option names on January 12th
3M ago
ALB
APH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >